BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34814099)

  • 1. Interactions of comorbid neuropsychiatric subsyndromes with neurodegenerative and cerebrovascular pathologies on cognition.
    Kan CN; Xu X; Schmetterer L; Venketasubramanian N; Chen C; Tan CH
    Neurobiol Aging; 2022 Jan; 109():239-246. PubMed ID: 34814099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.
    Ozzoude M; Varriano B; Beaton D; Ramirez J; Adamo S; Holmes MF; Scott CJM; Gao F; Sunderland KM; McLaughlin P; Goubran M; Kwan D; Roberts A; Bartha R; Symons S; Tan B; Swartz RH; Abrahao A; Saposnik G; Masellis M; Lang AE; Marras C; Zinman L; Shoesmith C; Borrie M; Fischer CE; Frank A; Freedman M; Montero-Odasso M; Kumar S; Pasternak S; Strother SC; Pollock BG; Rajji TK; Seitz D; Tang-Wai DF; Turnbull J; Dowlatshahi D; Hassan A; Casaubon L; Mandzia J; Sahlas D; Breen DP; Grimes D; Jog M; Steeves TDL; Arnott SR; Black SE; Finger E; Rabin J; ; Tartaglia MC
    Alzheimers Res Ther; 2023 Jun; 15(1):114. PubMed ID: 37340319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease.
    Xu X; Phua A; Collinson SL; Hilal S; Ikram MK; Wong TY; Cheng CY; Venketasubramanian N; Chen C
    Stroke Vasc Neurol; 2019 Sep; 4(3):135-140. PubMed ID: 31709119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankle brachial index, MRI markers and cognition: The Epidemiology of Dementia in Singapore study.
    Shaik MA; Venketasubramanian N; Cheng CY; Wong TY; Vrooman H; Ikram MK; Hilal S; Chen C
    Atherosclerosis; 2017 Aug; 263():272-277. PubMed ID: 28709046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid amyloid with cerebrovascular disease in domain-specific cognitive and neuropsychiatric disturbances: a cross-sectional memory clinic study.
    Kan CN; Huang X; Zhang L; Hilal S; Reilhac A; Tanaka T; Venketasubramanian N; Chen C; Xu X
    Neurobiol Aging; 2023 Dec; 132():47-55. PubMed ID: 37729769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population.
    Gyanwali B; Shaik MA; Venketasubramanian N; Chen C; Hilal S
    J Alzheimers Dis; 2019; 71(4):1309-1320. PubMed ID: 31524167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global cerebrovascular burden and long-term clinical outcomes in Asian elderly across the spectrum of cognitive impairment.
    Xu X; Chan YH; Chan QL; Gyanwali B; Hilal S; Tan BY; Ikram MK; Venketasubramanian N; Chen CL
    Int Psychogeriatr; 2018 Sep; 30(9):1355-1363. PubMed ID: 29665875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment.
    Chai YL; Chong JR; Raquib AR; Xu X; Hilal S; Venketasubramanian N; Tan BY; Kumar AP; Sethi G; Chen CP; Lai MKP
    Sci Rep; 2021 Feb; 11(1):4010. PubMed ID: 33597603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample.
    Xu X; Hilal S; Collinson SL; Chan QL; Yi Chong EJ; Ikram MK; Venketasubramanian N; Cheng CY; Wong TY; Chen CL
    J Alzheimers Dis; 2016 Apr; 52(3):1021-8. PubMed ID: 27079726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
    Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
    Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
    Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical cerebral microinfarcts on 3T MRI: A novel marker of cerebrovascular disease.
    Hilal S; Sikking E; Shaik MA; Chan QL; van Veluw SJ; Vrooman H; Cheng CY; Sabanayagam C; Cheung CY; Wong TY; Venketasubramanian N; Biessels GJ; Chen C; Ikram MK
    Neurology; 2016 Oct; 87(15):1583-1590. PubMed ID: 27590296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cerebral Small Vessel Disease Burden with Neuropsychiatric Symptoms in Non-Demented Elderly: A Longitudinal Study.
    Cao QL; Sun Y; Hu H; Wang ZT; Tan L; Yu JT;
    J Alzheimers Dis; 2022; 89(2):583-592. PubMed ID: 35912738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter network damage mediates association between cerebrovascular disease and cognition.
    Hilal S; Liu S; Wong TY; Vrooman H; Cheng CY; Venketasubramanian N; Chen CL; Zhou JH
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):1858-1872. PubMed ID: 33530830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
    Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin ÅK; van Buchem MA; Oleksik A; Verbeek MM; Olde Rikkert M; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
    Alzheimers Res Ther; 2017 Dec; 9(1):101. PubMed ID: 29284531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory.
    Canevelli M; Adali N; Voisin T; Soto ME; Bruno G; Cesari M; Vellas B
    Int J Geriatr Psychiatry; 2013 Aug; 28(8):795-803. PubMed ID: 23147419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Neurovascular and Neurodegenerative Magnetic Resonance Imaging Measures in Stroke.
    Wyss A; Dawson J; Arba F; Wardlaw JM; Dickie DA
    Stroke; 2019 May; 50(5):1136-1139. PubMed ID: 31009345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    Defrancesco M; Marksteiner J; Kemmler G; Dal-Bianco P; Ransmayr G; Benke T; Mosbacher J; Höller Y; Schmidt R
    J Alzheimers Dis; 2020; 73(1):125-133. PubMed ID: 31744004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.